Literature DB >> 11747812

IKKalpha provides an essential link between RANK signaling and cyclin D1 expression during mammary gland development.

Y Cao1, G Bonizzi, T N Seagroves, F R Greten, R Johnson, E V Schmidt, M Karin.   

Abstract

To identify functions of the IKKalpha subunit of IkappaB kinase that require catalytic activity, we generated an Ikkalpha(AA) knockin allele containing alanines instead of serines in the activation loop. Ikkalpha(AA/AA) mice are healthy and fertile, but females display a severe lactation defect due to impaired proliferation of mammary epithelial cells. IKKalpha activity is required for NF-kappaB activation in mammary epithelial cells during pregnancy and in response to RANK ligand but not TNFalpha. IKKalpha and NF-kappaB activation are also required for optimal cyclin D1 induction. Defective RANK signaling or cyclin D1 expression results in the same phenotypic effect as the Ikkalpha(AA) mutation, which is completely suppressed by a mammary specific cyclin D1 transgene. Thus, IKKalpha is a critical intermediate in a pathway that controls mammary epithelial proliferation in response to RANK signaling via cyclin D1.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11747812     DOI: 10.1016/s0092-8674(01)00599-2

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   41.582


  173 in total

1.  IKKalpha regulates mitogenic signaling through transcriptional induction of cyclin D1 via Tcf.

Authors:  Chris Albanese; Kongming Wu; Mark D'Amico; Christy Jarrett; David Joyce; Julian Hughes; James Hulit; Toshiyuki Sakamaki; Maofu Fu; Avri Ben-Ze'ev; Jacqueline F Bromberg; Carmela Lamberti; Udit Verma; Richard B Gaynor; Stephen W Byers; Richard G Pestell
Journal:  Mol Biol Cell       Date:  2003-02       Impact factor: 4.138

2.  Suppression of the novel ER protein Maxer by mutant ataxin-1 in Bergman glia contributes to non-cell-autonomous toxicity.

Authors:  Hiroki Shiwaku; Natsue Yoshimura; Takuya Tamura; Masaki Sone; Soichi Ogishima; Kei Watase; Kazuhiko Tagawa; Hitoshi Okazawa
Journal:  EMBO J       Date:  2010-06-08       Impact factor: 11.598

Review 3.  IκB kinase alpha and cancer.

Authors:  Shuang Liu; Zhisong Chen; Feng Zhu; Yinling Hu
Journal:  J Interferon Cytokine Res       Date:  2011-12-07       Impact factor: 2.607

Review 4.  Apoptosis regulation in the mammary gland.

Authors:  K A Green; C H Streuli
Journal:  Cell Mol Life Sci       Date:  2004-08       Impact factor: 9.261

Review 5.  Microarray analysis of the involution switch.

Authors:  Richard W E Clarkson; Christine J Watson
Journal:  J Mammary Gland Biol Neoplasia       Date:  2003-07       Impact factor: 2.673

6.  Functional development of the mammary gland: use of expression profiling and trajectory clustering to reveal changes in gene expression during pregnancy, lactation, and involution.

Authors:  Michael C Rudolph; James L McManaman; Larry Hunter; Tzulip Phang; Margaret C Neville
Journal:  J Mammary Gland Biol Neoplasia       Date:  2003-07       Impact factor: 2.673

Review 7.  Nuclear factor (NF)-kappaB proteins: therapeutic targets.

Authors:  I M Verma
Journal:  Ann Rheum Dis       Date:  2004-11       Impact factor: 19.103

Review 8.  The nuclear factor NF-kappaB pathway in inflammation.

Authors:  Toby Lawrence
Journal:  Cold Spring Harb Perspect Biol       Date:  2009-10-07       Impact factor: 10.005

Review 9.  Role of IKKα in skin squamous cell carcinomas.

Authors:  Eunmi Park; Bigang Liu; Xiaojun Xia; Feng Zhu; Willette-Brown Jami; Yinling Hu
Journal:  Future Oncol       Date:  2011-01       Impact factor: 3.404

10.  Phosphorylated FADD induces NF-kappaB, perturbs cell cycle, and is associated with poor outcome in lung adenocarcinomas.

Authors:  Guoan Chen; Mahaveer S Bhojani; Andrew C Heaford; Daniel C Chang; Bharathi Laxman; Dafydd G Thomas; Laura B Griffin; James Yu; Julia M Coppola; Thomas J Giordano; Lin Lin; David Adams; Mark B Orringer; Brian D Ross; David G Beer; Alnawaz Rehemtulla
Journal:  Proc Natl Acad Sci U S A       Date:  2005-08-18       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.